TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive In Brief: Cancer Prevention Fellowship Program Application Sought; Grant Funds Available March 18, 1994